



















doi:10.101Microchimerism in Salivary Glands after Blood- and
Marrow-Derived Stem Cell Transplantation
Simon D. Tran,1 Robert S. Redman,2 A. John Barrett,3 Steven Z. Pavletic,4 Sharon Key,5
Younan Liu,1 Ashley Carpenter,4 Hieu M. Nguyen,1 Yoshinori Sumita,1,6
Bruce J. Baum,5 Stanley R. Pillemer,7 Eva Mezey5Blood- andmarrow-derived stem cells (BMDSCs) provide disease-ameliorating effects for cardiovascular and
autoimmune diseases. Microchimerism from donor BMDSCs has been reported in several recipient tissues.
We hypothesized that this finding suggests a potential use of BMDSCs in the treatment of salivary dysfunc-
tions. We investigated the presence of Y chromosome-positive cells in salivary gland biopsies of 5 females
who had received a marrow or blood stem cell transplant from male donors. One to 16 years after trans-
plantation, all recipients exhibited scattered Y chromosome-positive cells in the acini, ducts, and stroma
of their salivary glands (mean of 1.01%). Potentially, these cells can be markers of transplantation tolerance,
contribute to neoplastic epithelial tissues, or engraft at sites of injury. In addition, transplantation of BMDSCs
could be used for treatment of Sj€ogren’s syndrome and salivary glands damaged by therapeutic irradiation for
cancers of the head and neck.
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Recent reviews suggest transplantation of blood-
and marrow-derived stem cells (BMDSCs) provide
disease-ameliorating effects for cardiovascular and
autoimmune diseases [1,2]. Microchimerism arising
from BMDSCs and organ transplantations has been
reported in a variety of recipient tissues (heart, liver,
kidney, gastrointestinal [GI] tract, lung, endometrium,
buccal epithelium) [3-12]. We hypothesized that this
phenomenon has implications for the potential use of
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6/j.bbmt.2010.09.021(eg, Sj€ogren’s syndrome and salivary glands damaged
by irradiation) for which no suitable conventional
treatments are currently available. Here we report, for
the first time, evidence of microchimerism resulting
from BMDSCs in salivary glands of recipients.METHODS
This study was approved by the institutional review
boards at McGill University, National Institutes of
Health, andVeteransAffairsMedicalCenter.Labial sal-
ivary gland tissue was collected from 5 female subjects
who had previously received either an allogeneic bone
marrow or peripheral blood stem cell transplant from
their brothers (Table 1).This gender-mismatched strat-
egy allowed us to detect donor Y chromosomes in cells
of the female-recipient salivary tissue. At the time of sal-
ivary gland biopsy, all patientswerewell, in hematologic
remission, with full donor lymphohematopoietic
engraftment. We chose to biopsy minor labial salivary
glands because they share abundant similarities with
the major salivary glands (ie, parotid, submandibular,
and sublingual glands), they are routinely used to obtain
information about all salivary tissue in patients with
Sj€ogren’s syndrome and they can be obtained with little
discomfort and morbidity compared to biopsies from
the major glands [13]. We performed colocalization
techniques to genetic and protein markers as we de-
scribed previously [10]. Using fluorescence microscopy429
Table 1. Characteristics of the Female Transplant Recipients
#1 #2 Recipient #3 #4 #5
Characteristic
Age at transplant (years) 31 36 37 52 28
Reason for transplant CML chronic phase MDS (RAEB) AML CR1 Aplastic anemia CML chronic phase







Cy 120, Flu 125,
ATG 120
Cy 120, AraC 500
TBI 5.5 Gy
Time from transplant to salivary gland biopsy 57 months 50 months 40 months 13 months 201 months





History of blood transfusion Never Yes Yes Yes Yes
GVHD COP None Liver Skin, oral Skin, oral
Active at time of biopsy no — no yes yes
% of positive male cells in salivary gland 1.09% 0.95% 0.65% 0.92% 1.44%
% of positive male cells in buccal mucosa 11.3% 2.4% 12.7% n/a n/a
AML CR1 indicates acute myelogenous leukemia in first complete remission; AraC, Cytarabine 500 mg/m2; ATG, antithymocyte globulin 120 mg/kg; BM,
bone marrow transplant; CML, chronic myelogenous leukemia; COP, cryptogenic organizing pneumonia; Cy, Cyclophosphamide 120 mg/kg; Flu, Fludar-
abine 125 mg/m2; MDS (RAEB), myelodysplastic syndromewith excess of blasts; PBSC, peripheral blood stem cell transplant; TBI, total-body irradiation;
GVHD, graft-versus-host disease.
430 Biol Blood Marrow Transplant 17:429-433, 2011S. D. Tran et al.on 10-mm-thick frozen salivary tissue sections: (1) cells
from the male donors were identified using fluores-
cence in situ hybridization (FISH) using a human Y
chromosome probe conjugated with digoxigenin and
visualized with Tyramide-FITC, and in the same sec-
tions, (2) salivary epithelial cells were identified by the
presence of epithelial markers (cytokeratins; CK) using
fluorescence immunohistochemistry (FIHC). The CK
antibodies (BioGenex, San Ramon, CA) stain the sali-
vary gland parenchymal cellswhile leaving nonepithelial
cells (such as endothelial cells, stromal cells, and blood
cells) unstained. We further determined whether male
donor BMDSCs had fused with female recipient cells
using FISH with X and Y chromosomal probes (Vysis,
Downers Grove, IL). The sensitivity and specificity of
the Y and X chromosomal probes used was between
97% and 100% [10]. As negative and positive controls,
the DNA probes and antibodies were tested on labial
salivary glands of normal healthy male and female
volunteers.RESULTS AND DISCUSSION
One to 16 years after male-to-female BMDSC
transplantation, all 5 female recipients had Y chromo-
some-positive salivary cells (mean of 1.01%, range:
0.65%-1.44%) in the gland parenchymal tissue
(Table 1). Our Y chromosome probe used in FISH
has a false-positive rate between 0% to 0.2%, and
a false-negative rate between 1.5% to 3.1% (ie, we
were using aY chromosome probe that underestimated
the true frequency of Y chromosome-positive cells, but
was unlikely to overestimate it). These Y chromosome-
positive cells expressed CK-8, -9, -13, -18 (markers for
salivary cells) (Figure 1A-C). Many of these cells were
identified in each of the parenchymal components of
the glands, that is, acini and intercalated, striated, andexcretory ducts. We also used the following markers
to further characterize the phenotypes of the Y chro-
mosome-positive cells (Figure 1D-F): Na1
-K1-2Cl2 cotransporter (NKCC1, a marker for acini;
donated by R.J. Turner), claudin-1 (a tight junction
protein in salivary ducts; Zymed, San Francisco, CA),
and vonWillebrand factor IV (amarker for endothelial
cells; Novocastra, Newcastle, UK). Our salivary gland
specimens had few foci of lymphocytic infiltration.
However, in situations where these lymphocytic infil-
trations were detected by H&E staining in proximity
to salivary cells, we immunostained an additional slide
combining a hematopoietic lineage (CD45) marker, an
epithelial marker (NKCC1) and the Y chromosome
probe. This modification of the technique described
earlier [14] using different fluorescent colors, showed
scattered Y1/CD451 cells in the stroma, but these
were exceedingly rare in the epithelial structures
(Figure 1G). Therefore, we conclude that the vast
majority of the Y chromosome-positive cells in the
intercalated ducts and acini of our specimens were of
epithelial phenotype. Inmore than 1000 cells examined
per patient, we detected no XXXY-positive cells (no
cell fusion events).We previously reported in our stud-
ies of buccal epithelial cells in a female recipient that
DNA genotyping had excluded the possibility that all
observed Y chromosome-positive cells were trans-
ferred in utero by her son during pregnancy (a process
referred to as fetal microchimerism) [10].
Our results indicate that a small percentage (about
1%) of cells derived from marrow or granulocyte-
colony stimulating factor (G-CSF) mobilized blood
cells can migrate into the salivary glands. Higher rates
of microchimerism seem to occur in tissues with high
cell turnover rates and/or that are sites of frequent in-
juries, for example, buccal (oral) epithelial cells
(10%) [10], endometrial glands [12,15], skin
(20%) [16], and liver (25%; an organ exposed to
Figure 1. Labial salivary gland biopsies from female recipients of male BMDSCs. (A) Salivary cells are stained with the epithelial marker cytokeratin 13
(green). Y chromosome-positive cells (nuclei with red fluorescent dots, shown by the arrows) reside in an intercalated duct (left) and a striated duct
(right). (B, C) Cytokeratins 8, 18, 19 are shown in red. Y-positive cells (green) reside in epithelial cells (arrows) and stromal cells (arrowheads). Panel C
shows 3 planes restored from a Z-stack of sections taken at 0.5-mm intervals. The y and z dimensions are shown on the two sides of the x plane image and
demonstrate the presence of the Y chromosome (green) in the same plane with the cytokeratins (red) and the nuclei (DAPI, blue). Further character-
ization of the phenotypes of Y chromosome-positive cells using additional cell markers (shown in green) such as: (D) claudin-1 (a tight junction protein in
salivary ducts), (E) Na1-K1-2Cl2 cotransporter (NKCC1; a marker for acini), and (F) vonWillebrand factor IV (a marker for endothelial cells) indicate
several epithelial and endothelial cells that are Y chromosome-positive (arrows); other Y-positive cells (arrowheads) in or near the wall of this blood
vessel may be smooth muscle cells, fibroblasts, etc. (G) CD45 (a marker of the white blood cell lineage) in green (FITC); NKCC1 in yellow (CY5) and the
Y chromosome in red (Alexa-594). All nuclei are blue (DAPI). The two arrows point to 2 CD45-positive cells in proximity to salivary cells. The inter-
section of the 2 red lines in this panel indicates a salivary epithelial cell (NKCC1, yellow) of male donor origin (Y chromosome, red dot). Panels D-G
show 3 planes restored from a Z-stack of sections taken at 0.5-mm intervals. Scale bars equal 10 mm (A-C) and 16 mm in D-G.
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compare our previous results on buccal cells to the re-
sults presented in this article in the partially overlap-
ping patient population (3 out of the 5 patients were
the same in both studies). The comparison clearly
shows that tissues with high turnover rates (ie, the buc-
cal epithelium) might need to replace stem cells more
frequently during the life-span of the individual than
tissues with slow turnover rates (ie, salivary glands).
We found almost 10 times more differentiated epithe-
lial cells of donor origin in the oral mucosa than in sal-
ivary glands of the same patients (Table 1).
The physiological significance of finding micro-
chimerism in recipients’ tissues after donor BMDSCs
or organ transplantations is at present unclear. Ayala
et al. [17] suggest using donor chimerism as a marker
of transplantation tolerance that may help to tailor
immunosuppressive treatment. Other groups have
suggested that microchimerism might contribute to
the development of neoplastic epithelial tissues
[18,19]. However, this remains unresolved as there
are also data arguing against the possibility that
BMDSCs represent a direct source of carcinomas in
the recipients [20]. There are reports of better
BMDSC donor cell engraftment at sites with injury,
such as lung after radiation [6], GI inflammation
[21], and skin blistering [16]. Regarding the latter in-
jury, Wagner et al. [16] showed histologic evidence
of increased amounts of collagen type VII (C7) at the
dermal-epidermal junction of children with recessive
dystrophic epidermolysis bullosa, a genetic skin disor-
der caused by amutation in the C7 gene. They hypoth-
esized that donor BMDSCs mobilized to the skin
secreted C7, which resulted in reduced blistering and
increased clinical benefit for their patients. Of particu-
lar interest with the findings reported here are specific
injuries that occur to the salivary glands, such as from
therapeutic radiation for head and neck cancers and
autoimmune insults in Sj€ogren’s syndrome. These in-
juries (either radiation induced or immunologic) might
increase donor cell engraftment/microchimerism. A
more efficient delivery of BMDSCs into irradiation-
damaged salivary glandsmight be achieved via infusion
up the ductal tree [22]. For now, we demonstrate, as
a proof-of-concept, that donor cell microchimerism
can be identified in human salivary glands.ACKNOWLEDGMENTS
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